Parker et al. speculated that the IL-24 anticancer effect could be associated with IFN-αβ expression triggered by the activation of PKR by cytosolic IL-24, since IFN-αβ plays a direct effect on target cancer cells by activating immune responses [49]. This evidence concerns the gene IL24 and cancer.